Analysis of Urinary Proteome Modifications in Patients with Different Glycated Hemoglobin A1c Levels
International Journal of Molecular Sciences · 28.03.2026 · 27 (7) · 3100
DOI: 10.3390/ijms27073100 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2026. Verfasst von Yuzhen Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gene Engineering Drug and Biotechnology Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Proteome, Diabetes Mellitus, Type 2. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Beijing Natural Science Foundation, Beijing Normal University.
Abstract (Originalsprache)
Diabetes, a major global public health concern, requires early diagnosis and timely intervention. Glycated hemoglobin A1c (HbA1c) serves as a biomarker of glycemic management, with its levels showing a continuous relationship with the risk of developing diabetes. In this study, urinary proteome modifications were compared between each of the two patient groups with different HbA1c levels ([6.4 ± 0.7]% and [8.6 ± 1.6]%) and healthy controls. A total of 1954 and 5545 differentially modified peptides were identified in the two groups, respectively. Within each group, differentially modified peptides exhibiting changes from presence to absence or vice versa accounted for 48.8% and 86.5%, respectively. Additionally, results from the randomized grouping test indicated that at least 90.6% and 94.1% of these differentially modified peptides in each group were not randomly generated. In conclusion, urinary proteome modifications comprehensively and systematically reflect changes associated with elevated HbA1c levels, with distinct modification profiles corresponding to different HbA1c levels. These findings suggest that urinary proteome modifications have the potential to reflect HbA1c levels and offer a new perspective for research on the early diagnosis of diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene Engineering Drug and Biotechnology Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing 100875, China.
ORCID-Profile: Yuzhen Chen, Youhe Gao
Förderung
- National Key R&D Program of China
- Beijing Natural Science Foundation
- Beijing Normal University
- National Key R&D Program of China
Zitieren
APA
Chen, Y., & Gao, Y. (2026). Analysis of Urinary Proteome Modifications in Patients with Different Glycated Hemoglobin A1c Levels. International Journal of Molecular Sciences, 27(7), 3100. https://doi.org/10.3390/ijms27073100
Vancouver
Chen Y, Gao Y. Analysis of Urinary Proteome Modifications in Patients with Different Glycated Hemoglobin A1c Levels. International Journal of Molecular Sciences. 2026;27(7):3100. doi:10.3390/ijms27073100
BibTeX
@article{Chen2026,
author = {Chen, Yuzhen and Gao, Youhe},
title = {Analysis of Urinary Proteome Modifications in Patients with Different Glycated Hemoglobin A1c Levels},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3100},
doi = {10.3390/ijms27073100}
}
EUVIMED